Rosalind Advisors »

Anavex Life Sciences Corp put shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Anavex Life Sciences Corp put shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Anavex Life Sciences Corp put

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences Corp put held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences Corp put by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 1.2M 1.61

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Anavex Life Sciences Corp put

Rosalind Advisors
Group One Trading
Aristides Capital
Simplex Trading
National Bank Of Canada /fi/

View all funds holding Anavex Life Sciences Corp put